Publication | Closed Access

Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease

Lipid PeroxidationImmunologyPathologyFatty Liver DiseaseOxidative StressInflammationMetabolic SyndromeNonalcoholic Fatty Liver DiseaseHepatotoxicityHealth SciencesInflammatory CytokinesMetabolic Associated SteatohepatitisLiver PhysiologyHepatology InflammationPharmacologyInsulin ResistanceHepatologyLiver DiseaseMedicine